Management of retinitis pigmentosa by Wharton’s jelly-derived mesenchymal stem cells: prospective analysis of 1-year results

Table 2 Change of the functional parameters of the retina according to study timepoints

Patient No.	Eye	BCVA			FPDI			ERG amplitudes			ERG implicit times
Patient No.	Eye	T0	T1	T2	T0	T1	T2	T0	T1	T2	T0	T1	T2
1	R	100	110	110	5	11	12	3.2	6.3	6.4	43.8	38.8	38.7
2	L	80	87	90	6	16	19	2.1	2.3	2.6	42.7	42.7	40.8
3	R	80	88	88	10	12	12	1.5	3.0	2.9	42.3	40.7	40.4
4	L	84	88	91	6	10	11	1.9	4.1	4.0	40.3	40.0	39.9
5	L	50	74	50	4	7	5	2.4	11.1	2.6	47.4	42.5	46.3
6	L	80	85	85	7	13	14	3.6	19.7	19.9	50.0	50.0	49.8
7	R	50	56	60	15	22	23	1.6	2.7	2.8	50.0	50.0	49.8
8	L	80	87	87	5	7	7	1.4	2.4	2.3	50.0	46.1	45.8
9	L	72	79	79	8	14	14	2.0	2.5	2.6	44.6	42.1	42.0
10	L	50	55	55	14	19	18	4.4	6.0	5.8	38.5	34.9	35.0
11	R	65	77	77	5	10	9	1.0	4.1	3.8	44.1	35.7	36.0
12	R	65	74	74	4	8	8	11.0	16.9	16.3	26.9	26.7	26.8
13	L	65	87	87	5	9	10	1.4	7.4	7.6	43.4	22.8	22.4
14	R	50	69	70	14	26	26	2.8	3.9	4.0	38.6	34.0	39.9
15	L	89	110	110	4	16	16	2.0	2.7	2.8	38.1	38.0	37.8
16	R	80	83	77	5	5	4	0.9	1.3	0.9	49.1	34.1	42.9
17	L	50	59	60	6	6	7	1.7	4.0	4.0	32.8	23.5	24.0
18	L	80	85	85	10	12	12	1.5	8.9	8.8	34.8	22.5	23.5
19	R	50	65	65	14	15	15	1.3	4.9	4.9	40.8	32.1	32.7
20	R	60	77	77	10	12	13	1.6	1.8	2.0	49.2	49.2	49.0
21	R	50	59	60	4	5	5	1.5	1.8	1.8	44.0	44.0	43.8
22	L	77	87	87	8	10	11	2.6	3.0	3.0	46.0	43.5	43.8
23	R	70	70	70	10	10	10	5.0	5.1	5.0	48.2	48.2	48.0
24	L	98	110	110	7	10	11	1.5	2.7	2.7	39.6	24.4	24.2
25	L	85	91	91	10	16	18	1.4	1.9	2.1	35.7	29.0	29.0
26	L	89	110	110	7	10	10	5.0	8.9	8.7	41.6	35.2	35.2
27	R	85	94	94	10	12	12	2.0	2.8	2.9	48.2	46.8	46.0
28	R	50	55	50	4	4	4	1.8	9.6	3.6	46.0	34.0	39.0
29	R	50	50	50	5	5	5	2.8	6.6	4.8	39.5	39.5	39.3
30	L	89	94	94	6	8	8	0.7	2.9	2.8	48.8	36.6	37.0
31	R	74	85	85	15	16	16	1.6	3.3	3.2	48.2	44.1	44.0
31	L	80	87	87	14	15	15	2.0	2.8	2.8	47.4	43.2	43.2
32	R	60	77	77	8	11	11	1.9	2.0	2.0	44.0	36.0	37.0
32	L	60	77	77	7	10	10	1.5	1.7	1.7	47.0	38.0	39.0

BCVA best corrected visual acuity (ETDRS letters), FPDI fundus perimetry deviation index (%), ERG amplitudes full-field flicker electroretinography amplitudes (mV), ERG implicit times full-field flicker electroretinography implicit times (ms), T0 (baseline) just before the Wharton jelly-derived mesenchymal stem cell injection, T1 6th month after injection, T2 12th month after injection

ISSN: 1757-6512